Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after difinitive treatments for squamous cell carcinoma of the head and neck

Head and Neck

Volumn 26, Issue 12, 2004, Pages 1008-1017

  Ware, Robert E ^a   Matthews, Jane P ^a   Hicks, Rodney J ^a   Porceddu, Sandro ^a   Hogg, Annette ^a   Rischin, Danny ^a   Corry, June ^a   Peters, Lester J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Cervical lymph node metastasis; Positron emission tomography; Radiotherapy; Residual mass; Therapeutic response

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 10044248348     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20097     Document Type: Article

References (19)

1. Khuri FR, Shin DM, Glisson BS, Lippman SM, Hong WK. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Semin Oncol 2000;27:25-33.
2. Forastiere A, Trotti A. Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer. J Natl Cancer Inst 1999;91:2065-2066.
3. Chisin R. Nuclear medicine in head and neck oncology: reality and perspectives. J Nucl Med 1999;40:91-95.
4. Adams S, Baum RP, Stuckensen T, Bitter K, Hör G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255-1260.
5. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211.
6. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]-fluoro- D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-141.
7. McGuirt WF, Greven K, Williams Dr, et al. PET scanning in head and neck oncology: a review. Head Neck 1998;20:208-215.
8. Karp JS, Muehllehner G, Mankoff DA, et al. Continuous-slice PENN-PET: a positron tomograph with volume imaging capability. J Nucl Med 1990;31:617-627.
9. Karp JS, Muehllehner G. Standards for performance measurements of PET scanners - evaluation with the UGM PENN-PET 240H scanner. Med Progr Technol 1991;17:173-187.
10. 137Cs in whole body PET imaging. J Nucl Med 1999;40:1257-1263.
11. StatXact. 5.0.3 ed. Cambridge, MA: CYTEL Software Corporation; 2001.
12. S-Plus 2000. Seattle, WA: MathSoft Inc.; 1999.
13. SPSS for Windows. 10.0.7 ed. Chicago, IL: SPSS Inc.; 2000.
14. Keyes JW, Watson NE, Williams DW, Greven KM, McGuirt WF. FDG PET in head and neck cancer. AJR Am J Roentgenol 1997;169:1663-1669.
15. Lapela M, Eighted A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000;36:858-867.
16. Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000;18:651-658.
17. Lee HJ, Zelefsky MJ, Kraus DH, et al. Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma. Int J Radiat Oncol Biol Phys 1997;38:995-1000.
18. Narayan K, Crane CH, Kleid S, Hughes PG, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 1999;21:606-613.
19. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-435.